진통제 시장 규모, 점유율, 성장 분석 : 약물 유형별, 투여 경로별, 용도별, 유통 채널별, 지역별 - 업계 예측(2026-2033년)

Analgesics Market size was valued at USD 43.38 Billion in 2024 and is poised to grow from USD 46 Billion in 2025 to USD 73.42 Billion by 2033, growing at a CAGR of 6.02% during the forecast period (2026-2033).

The global analgesics market is experiencing consistent growth, fueled by several key factors. A rising prevalence of chronic pain conditions and an increasing geriatric population are significantly driving demand, alongside a heightened awareness of effective pain management strategies. Both prescription and over-the-counter analgesics are witnessing heightened demand due to their effectiveness in alleviating discomfort. Moreover, advancements in drug delivery systems and the introduction of innovative analgesic formulations, alongside a robust pipeline of generic options, are propelling further market expansion. Strategic collaborations and mergers among major players also play a crucial role, enhancing product portfolios and broadening their global presence in the analgesics landscape. This dynamic landscape reflects the increasing prioritization of pain relief solutions worldwide.

Top-down and bottom-up approaches were used to estimate and validate the size of the Analgesics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Analgesics Market Segments Analysis

Global Analgesics Market is segmented by drug type, route of administration, application, distribution channel and region. Based on drug type, the market is segmented into opioid analgesics and non-opioid analgesics. Based on route of administration, the market is segmented into oral, topical, injectable and transdermal. Based on application, the market is segmented into chronic pain, acute pain and other. Based on distribution channel, the market is segmented into hospital pharmacies, retail pharmacies and online pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Analgesics Market

The global analgesics market is significantly driven by the rising incidence of chronic pain conditions, which impact a large segment of the population and create an increasing demand for effective pain relief solutions. Conditions such as arthritis, cancer, neuropathic pain, and musculoskeletal disorders all contribute to this escalating burden. Consequently, there is a pressing need for analgesic medications that can alleviate pain and enhance patients' quality of life. Additionally, the growing awareness regarding the importance of pain management, combined with advancements in pharmaceutical research, stimulates the innovation and development of new and improved analgesic drugs, further propelling market expansion.

Restraints in the Analgesics Market

A major challenge faced by the global analgesics market is the risk of side effects and the potential for misuse associated with certain analgesic medications, particularly opioids. These opioid-based drugs are linked to issues such as dependence, addiction, and overdose, raising serious public health concerns. This has resulted in heightened scrutiny from regulatory bodies and the establishment of more stringent prescription practices. As a consequence, healthcare providers are becoming increasingly cautious when it comes to prescribing opioid analgesics, which is fueling a transition towards non-opioid alternatives and different pain management methods. Balancing the demand for effective pain relief while reducing the risk of abuse presents a significant obstacle to market growth.

Market Trends of the Analgesics Market

A significant trend shaping the global analgesics market is the rising preference for non-opioid analgesics driven by heightened awareness of the dangers associated with opioid use, including addiction and overdose risks. As healthcare professionals and patients alike seek safer pain management options, there is an increasing focus on utilizing non-opioid alternatives such as nonsteroidal anti-inflammatory drugs (NSAIDs) and acetaminophen, which are proving effective for alleviating mild to moderate pain. This shift reflects a broader movement towards responsible pain management practices and is fostering innovation in the development of new therapeutic agents that prioritize safety and efficacy.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Patent Analysis
• Case Studies
• Startup Analysis

Global Analgesics Market Size by Drug Type & CAGR (2026-2033)

• Market Overview
• Opioid Analgesics
  • Morphine
  • Fentanyl
  • Oxycodone
  • Hydrocodone
• Non-Opioid Analgesics
  • Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
  • Ibuprofen
  • Naproxen
  • Aspirin
  • Acetaminophen
  • Compound Analgesics

Global Analgesics Market Size by Route Of Administration & CAGR (2026-2033)

• Market Overview
• Oral
  • Tablets
  • Capsules
  • Liquids
• Topical
  • Creams
  • Gels
  • Patches
• Injectable
  • Intravenous
  • Intramuscular
• Transdermal

Global Analgesics Market Size by Application & CAGR (2026-2033)

• Market Overview
• Chronic Pain
  • Arthritis
  • Cancer Pain
  • Neuropathic Pain
• Acute Pain
  • Postoperative Pain
  • Injury Pain
• Other
  • Migraine
  • Fibromyalgia

Global Analgesics Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Global Analgesics Market Size & CAGR (2026-2033)

• North America (Drug Type, Route Of Administration, Application, Distribution Channel)
  • USA
  • Canada
• Europe (Drug Type, Route Of Administration, Application, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Drug Type, Route Of Administration, Application, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Drug Type, Route Of Administration, Application, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Drug Type, Route Of Administration, Application, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Pfizer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline plc (GSK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca PLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bristol-Myers Squibb Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AbbVie Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mylan N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Endo Pharmaceuticals Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Purdue Pharma L.P.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mallinckrodt Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Horizon Therapeutics plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sun Pharmaceutical Industries Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dr. Reddy's Laboratories Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zydus Cadila
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations